Immunocore R&D Head David Berman resigns effective Feb 27; no replacement planned

Immunocore Holdings plc

David Berman notified resignation as Head of R&D on Jan 27, 2026, effective Feb 27, 2026.
Resignation is voluntary to pursue another opportunity; not due to any disagreement with the Company.
Company will not seek a direct replacement; will streamline and leverage existing R&D structure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.